Резюме
Определение
Анамнез и осмотр
Ключевые диагностические факторы
- tosse
- dispneia
- produção de escarro
- exposição a fatores de risco
Другие диагностические факторы
- tórax em tonel
- hiper-ressonância/timpanismo à percussão
- murmúrio vesicular diminuído à ausculta pulmonar
- expansibilidade reduzida à ausculta
- sibilância à ausculta
- crepitação grossa
- taquipneia
- asterixis (flapping)
- veias jugulares distendidas
- edema de membros inferiores
- fadiga
- perda de peso
- perda muscular
- cefaleia
- Respiração com lábios franzidos
- cianose
- hiperfonese da segunda bulha no foco pulmonar (P2)
- refluxo hepatojugular
- hepatoesplenomegalia
- baqueteamento digital
Факторы риска
- tabagismo
- idade avançada
- fatores genéticos
- crescimento e desenvolvimento pulmonar
- ascendência branca
- exposição à poluição do ar
- exposição à queima de combustíveis sólidos ou biomassa
- exposição ocupacional a poeira, produtos químicos, pesticidas, vapores, fumaças ou gases
- sexo masculino
- condição socioeconômica baixa
- artrite reumatoide
Диагностические исследования
Исследования, которые показаны в первую очередь
- espirometria
- Escore de sintomas padronizados
- oximetria de pulso
- gasometria arterial
- Radiografia torácica
- Hemograma completo
Исследования, проведение которых нужно рассмотреть
- testes de função pulmonar
- tomografia do tórax
- medição seriada do pico do fluxo
- cultura de escarro
- nível de alfa 1-antitripsina
- teste ergométrico
- estudo do sono
- função do músculo respiratório
- eletrocardiograma (ECG)
- ecocardiograma
- contagem de eosinófilos no sangue
Алгоритм лечения
Составители
Авторы
Manoochehr Abadian Sharifabad, MD

Fountain Valley Regional Medical Center
Fountain Valley
CA
Раскрытие информации
MAS declares that he has no competing interests.
Выражение благодарностей
Dr Manoochehr Abadian Sharifabad would like to gratefully acknowledge Dr Jonathan P. Parsons and Dr Michael Ezzie, the previous contributors to this topic.
Раскрытие информации
JPP has contributed at speakers' bureaus for GlaxoSmithKline, Inc., Schering-Plough, Inc., and AstraZeneca, Inc. ME declares that he has no competing interests.
Рецензенты
Hormoz Ashtyani, MD, FCCP
Hackensack University Medical Center
Hackensack
NJ
Раскрытие информации
HA declares that he has no competing interests.
Alejandro Comellas, MD
Clinical Professor of Internal Medicine-Pulmonary, Critical Care and Occupational Medicine
University of Iowa
Iowa City
IA
Раскрытие информации
AC has received payments as a consultant for GSK and AstraZeneca. He also serves as a non-paid consultant for VIDA.
William Janssen, MD
Assistant Professor of Medicine
National Jewish Medical and Research Center
University of Colorado Health Sciences Center
Denver
CO
Раскрытие информации
WJ declares that he has no competing interests.
Francis Thien, MD, FRACP, FCCP
Associate Professor
Director of Respiratory Medicine
Eastern Health & Monash University
Victoria
Australia
Раскрытие информации
FT declares that he has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
Список литературы
Основные статьи
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2025 report. 2025 [internet publication].Полный текст
National Institute for Health and Care Excellence. Chronic obstructive pulmonary disease in over 16s: diagnosis and management. Jul 2019 [internet publication].Полный текст
Nici L, Mammen MJ, Charbek E, et al. Pharmacologic management of chronic obstructive pulmonary disease. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2020 May 1;201(9):e56-69.Полный текст Аннотация
Jacobs SS, Krishnan JA, Lederer DJ, et al. Home oxygen therapy for adults with chronic lung disease. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2020 Nov 15;202(10):e121-41. [Erratum in: Am J Respir Crit Care Med. 2021 Apr 15;203(8):1045-6.]Полный текст Аннотация
Статьи, указанные как источники
A full list of sources referenced in this topic is available here.
Использование этого контента попадает под действие нашего заявления об отказе от ответственности
